Bookmark

Add to MyYahoo RSS

Celgene News

News on Celgene (Ticker: CELG) continually updated from thousands of sources around the net.

10 hrs ago | TheCelebrityCafe

Scientists find that cancer-fighting drug romidepsin aids in detection of HIV

Scientists from Aarhus University in Demark have found that cancer-fighting Istodax, also known as romidepsin and produced by Celgene Corp., activates the HIV virus that hides in CD4 cells.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Jul 18, 2014

Benzinga

Biotech Enters Reporting Season With Large Caps Central To Sector Performance

Biotech stock stocks enter their earnings season with investors increasingly interested in the long-term outlook for product pipelines, although large-cap growth stocks remain central to the sectors performance, an analyst said Friday.

Comment?

Related Topix: Financial Markets, Biotech, Biogen Idec, Hemophilia, Health, Medicine, Gilead Sciences, Healthcare Industry, Startups

Wed Jul 16, 2014

Seeking Alpha

Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron

Discovery and development platforms can efficiently multiply a drug pipeline. Regeneron leveraged its platforms to become a biotech paragon over the 5 years prior to 2014.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Sangamo Biosciences, Startups, Genetics, Biology, Science, Celgene

Thu Jul 10, 2014

Seeking Alpha

Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On

Cramer consulted the technical analysis of Bob Lang to see what the charts are saying about the "Four Horsemen of Biotech": Celgene , Regeneron , Biogen Idec and Gilead .

Comment?

Related Topix: Biotech, Medicine, Celgene, Regeneron Pharmaceuticals, Healthcare Industry, Gilead Sciences, Financial Markets, Williams Companies, Energy, Oil & Gas

Wed Jul 09, 2014

Value Line

Stock Market Today: July 9, 2014

Stocks to Watch from The Survey - Second-quarter earnings season kicked off after the market closed yesterday, when Alcoa released June-period financials.

Comment?

Related Topix: Financial Markets, Bob Evans Farms, Restaurant Management, Biotech, Medicine, Celgene, Healthcare Industry

Benzinga

Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback

Shares of Celgene have been volatile since the company announced weak Phase III trial results for OTEZLA Wednesday morning.

Comment?

Related Topix: Celgene, Biotech, Medicine, Healthcare Industry

BioSpace

Celgene Corporation's OTEZLA Misses Mark In Phase 3 Spinal Arthritis Study

Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLAA in Ankylosing Spondylitis Phase III POSTURE Study Did Not Achieve Primary Endpoint of ASAS 20 at Week 16 Based on Efficacy and Safety Data at Week 24, the Independent Data Monitoring Committee Recommended Continuation of the Phase III POSTURE Study Without Change In ... (more)

Comment?

Related Topix: Biotech, Medicine, Arthritis, Health, Healthcare Industry, Celgene, Psoriatic Arthritis, Healthcare Law, Law

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

At 9 a.m. EDT, senior management wi... )--Celgene Corporation ha annunciato in data odierna i risultati dello studio di fase III POSTURE per la valutazione del farmaco della societa OTEZLA... Celgene publie les rsultats de POSTURE, l'tude de phase III valuant OTEZLA en solution orale pour le traitement de la spondylarthrite ankylosante )--Celgene ... (more)

Comment?

Related Topix: ITT Industries, Manufacturing, Industrial Machines, ITT Corporation, Biotech, Medicine, Healthcare Industry, Celgene, Alkermes, Patent / Trademark Law, Law

Tue Jul 01, 2014

GuruFocus.com

Playing To The Strengths Of Biotech

The biotech sector is not the gamble it was in recent years. The industry is quickly becoming a perfect investment storm of improved drug development technology and clinical testing, more efficient FDA approvals, and better funding in venture capital.

Comment?

Related Topix: Biotech, Medicine, Celgene, Healthcare Industry

Business Journal

Bluebird bio in deal to buy Seattle biotech for up to $156M

Cambridge biotech bluebird bio has acquired Precision Genome Engineering Inc., a Seattle-based biotech, in a cash and stock deal valued at up to $156 million.

Comment?

Related Topix: Biotech, Healthcare Industry

Investor's Business Daily

Celgene Corporation to Announce Second Quarter 2014 Results on July...

Celgene Corporation will host a conference call and live audio webcast on Thursday, July 24, 2014 at 9 a.m. ET to discuss second quarter 2014 financial and operational results.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jun 30, 2014

AmericanBankingNews.com

Celgene PT Lowered to $126.00

Nomura's price target would suggest a potential upside of 45.16% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Celgene

Thu Jun 26, 2014

Seeking Alpha

IPO Preview: GlobeImmune

GBIM is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary TarmogenA platform.

Comment?

Related Topix: GlobeImmune, Infectious Diseases, Medicine, Louisville, CO, Biotech, Healthcare Industry, Gilead Sciences, National Institutes of Health

AmericanBankingNews.com

Celgene Receives Neutral Rating from Zacks

's stock had its "neutral" rating restated by Zacks in a research report issued to clients and investors on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Celgene

BioSpace

Celgene Corporation Mourns The Passing Of Board Of Director Member,

It is with great sadness that Celgene Corporation announces the death of Rodman L. Drake, a member of its Board of Directors since 2006.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Celgene

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The company will host a conference call to discuss... )--Intelsat S.A. , the world's leading provider of satellite services, announced today that it has signed a 15-year agreement with Encompass Digital Media, a glob... )--Horizon Energy Corporation says testing at the Holmes Oil Unit No.1 in Cherokee County, TX has confirmed the presence of oil & ... (more)

Comment?

Related Topix: Cherokee County, TX, Harman International Ind, Electronics, Biotech, Medicine, Healthcare Industry, Zeus Technology, Riverbed Technology, Startups

Tue Jun 24, 2014

Business Journal

Oregon investors raise questions about biotech money man

Life sciences investment banker and VC fund manager G. Steven Burrill's annual speech at the Biotechnology Industry Organization convention was cancelled as the industry fixture faces down charges of fraud in a civil lawsuit by a former employee.

Comment?

Related Topix: Biotech, Science / Technology, Venture Capital, Emerging Technology, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••